t Availability, access, life sustaining, conformity with state of art, non-harmful, effectiveness, and consumer satisfaction. framework of markers to evaluate the quality of seven dimensionst of genetic care, which have already been tested on overall health care in the French, German, UK, and US systems.2
Data collected so far show that genetics services in Europe vary greatly, particularly in the extent to which regional medical genetics centres are available, and staffed by trained clinicians and laboratory scientists.3 There are also great differences in the availability ofpopulation and pregnancy screening for genetic disorders. The UK is unusual in having developed extensive pregnancy screening for neural tube defects and Down syndrome, and screening for carriers of cystic fibrosis (albeit patchy and mainly research based). In contrast the social and legal environments appear unfavourable to population genetic screening in The Netherlands and Germany, as described by Niermeijer and Nippert at the workshop.
Primary care genetics
There are very different degrees ofdevelopment of primary care in the healthcare systems of Europe.7 The practicability of primary care genetics is linked to the structural characteristics of healthcare delivery system, especially the method of remuneration of doctors, particularly when this encourages overdiagnosis and treatment, rather than discussion and counselling. Where patients' choice of specialist is unconstrained by health service limits on resources, for example, in Germany, there seem to be few impediments to an expansion of genetic specialists other than the practicalities of training and resources.
Healthcare systems with highly developed primary care systems (for example, the UK) appear to offer many advantages to patients and to those at risk of genetic disorders8 and it was suggested by Sandy Raeburn that there is a natural partnership between primary care and medical genetics. Thus, in the UK, GPs are the points of first contact for most patients and filter referrals to specialists. However, more extensive roles for primary care in the provision of genetics services were discussed in the workshop. These included: (1) recognition of need, (2) appropriate referral to specialists, (3) continuing care of people and families with genetic problems, (4) timely counselling, (5) initiation of prenatal diagnosis and termination if requested, (6) education of patients.
The primary care team sees patients both by themselves and within their family framework, and can offer continuity of care, lifetime records, and a generalist approach to genetic disorders that affect all ages, all body systems, and multiple family members.
Pilot studies9 and contributions to the workshop by Hilary Harris, Fenby-Taylor, and Evans reported that in Britain with the help of genetic centres, primary care teams can successfully undertake counselling and genetic population screening. Primary care offers opportunities for targeted screening of high risk groups such as ethnic minority communities at risk of thalassaemia and sickle cell disease, as reported to the workshop by Nadeem Qureshi. Offer of screening in very early pregnancy, as shown by Hilary Harris in primary care, will allow prenatal diagnosis and termination of affected fetuses within the first trimester and after full counselling. Primary care involvement will be increasingly important as markers for Down syndrome move into the first trimester.
Obtaining consent before genetic screening is problematical and may be neglected as in some serum screening programmes for Down syndrome. Recent discussionl' has suggested the possibility of "generic consent". This would stress the common features of an increasing number of forms of antenatal screening and would avoid overloading patients with information. Could generic advice and consent also be obtained in primary care where the family is known to the doctor and the setting is familiar to the patient? This would reduce the need in the hospital antenatal clinic for potentially depressing discussions about fetal abnormality and termination.
The workshop discussed whether general practitioners can cope with genetics and several presentations showed untapped skills in primary care in the UK. However, in some countries primary care is not well developed and in the UK involvement in genetics may be slow because of current work practices and other constraints, including opposition from hospital specialists, insufficient time for genetic counselling, insufficient funds, and lack of training and knowledge, as reported by Fenby-Taylor. Identifying optimum genetics services will require clear definition of desired outcomes and these will be strongly influenced by the social structure and historic precedents in each European country. Health services research is needed to test various strategies for genetic services as discussed by Roland, Modell, Austoker, and others at the workshop.
Conclusions
Different arrangements for medical genetics services will be needed in countries with well developed primary care, compared with those where primary care is not well developed. In countries which do not have well developed primary care there may be uncontrolled increases in referrals to specialists and unacceptably long waiting lists in the absence of a major increase in numbers of specialists. Tara Clancy reported how genetic nurses, genetic counsellors, nurse practitioners, midwives, and other non-medical staff can provide an economic supplement to specialists and link primary care with genetic centres. They are particularly capable of supervising the long term support of families with genetic problems especially if this support is backed by an adequate longitudinal family record system. However, Germany, for example, seems set on a purely specialist service and there are doubts that genetic workers (genetic nurses, etc) will be encouraged with important implications for equal job opportunities within the EU. Similarly, with the exception of the UK and Denmark, confidentiality laws may inhibit longitudinal family record systems. The role of Public Health Medicine was discussed by Darren Shickle who stressed the importance of epidemiology and properly organised population genetic screening.
Specialist genetic centres will remain the core of a genetic service but will be greatly augmented by collaboration with other services to provide comprehensive facilities. In the UK there is concern also at present because of government moves to devolve priority setting for genetics, including for rare disorders, to fund holding GPs, most of whom have fewer than 20 000 patients on their lists. This has temporarily clouded the issue and in spite of the currently onerous work loads in general practice primary care is inevitably a partner in the provision of genetic services because of patients' expectations. GPs should be able to take a useful family history, recognise clues to increased genetic risk, be capable of relaying appropriate genetic information to patients, and above all to know how to obtain advice from genetic specialists.
It is currently impracticable and probably inappropriate for all existing general practitioners to be offered detailed training in medical genetics, but primary care teams would be greatly assisted by training packages and computerised guidelines on genetic problems, for example, familial breast and bowel cancer.
Specific genetic training should become part of the personal professional development of some established principals who are intent on developing special clinical interests and GP registrars should be exposed to genetics during vocational training programmes. Training in genetics could also become one of the clinical modules of the higher training in general practice. GP registrars are members of a generation that has grown up with computers and are well equipped to take advantages of new information technology.
A group was formed under the aegis of the Royal College of General Practitioners and the EC Concerted Action on Genetic Services in Europe with the support of the British Clinical Genetics Society and the European Society for Human Genetics to take forwards discussions on the role and training of primary care in the provision of genetics services.
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